Published in Br J Pharmacol on February 01, 1999
Reduction of nitrite to nitric oxide during ischemia protects against myocardial ischemia-reperfusion damage. Proc Natl Acad Sci U S A (2004) 3.23
Inhibition of c-Jun N-terminal kinase decreases cardiomyocyte apoptosis and infarct size after myocardial ischemia and reperfusion in anaesthetized rats. Br J Pharmacol (2004) 1.38
Prostanoid receptor antagonists: development strategies and therapeutic applications. Br J Pharmacol (2009) 1.31
Reduction of myocardial infarct size with sCR1sLe(x), an alternatively glycosylated form of human soluble complement receptor type 1 (sCR1), possessing sialyl Lewis x. Br J Pharmacol (1999) 0.83
Aquaporin-1 Deficiency Protects Against Myocardial Infarction by Reducing Both Edema and Apoptosis in Mice. Sci Rep (2015) 0.81
Magnesium Lithospermate B Protects Cardiomyocytes from Ischemic Injury Via Inhibition of TAB1-p38 Apoptosis Signaling. Front Pharmacol (2010) 0.78
Activation of E-prostanoid 3 receptor in macrophages facilitates cardiac healing after myocardial infarction. Nat Commun (2017) 0.75
The cardioprotective effect of microemulsion propofol against ischemia and reperfusion injury in isolated rat heart. Korean J Anesthesiol (2012) 0.75
International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev (1994) 5.11
Macroscopic identification of early myocardial infarcts by alterations in dehydrogenase activity. Am J Pathol (1963) 4.17
Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels. Possible mechanism of cardioprotection. Circ Res (1997) 3.41
Biochemical markers of myocardial injury. Is MB creatine kinase the choice for the 1990s? Circulation (1993) 2.16
Leukocytes and ischemia-induced myocardial injury. Annu Rev Pharmacol Toxicol (1986) 1.61
Relation between infarct size and ventricular arrhythmia. Br Heart J (1975) 1.41
Different types of myocardial necrosis in coronary heart disease: a pathophysiologic review of their functional significance. Am Heart J (1975) 1.38
Protein kinase C. Its role in ischemic preconditioning in the rat. Circ Res (1994) 1.34
Regional left ventricular performance in the year following myocardial infarction. Circulation (1972) 1.34
A critical look at currently used indirect indices of myocardial oxygen consumption. Basic Res Cardiol (1981) 1.20
Myofibrillar degeneration. A response of the myocardial cell to injury. Arch Pathol (1968) 1.20
Dissimilar effects of prostacyclin, prostaglandin E1, and prostaglandin E2 on myocardial infarct size after coronary occlusion in conscious dogs. Circ Res (1981) 1.07
Reduction by prostaglandin E1 or prostaglandin E0 of myocardial infarct size in the rabbit by activation of ATP-sensitive potassium channels. Br J Pharmacol (1995) 0.95
The effects of the endothelin ETA receptor antagonist, FR 139317, on infarct size in a rabbit model of acute myocardial ischaemia and reperfusion. Br J Pharmacol (1994) 0.88
Reduction of experimental canine myocardial infarct size with prostaglandin E1: inhibition of neutrophil migration and activation. J Pharmacol Exp Ther (1988) 0.86
Sulprostone-induced reduction of myocardial infarct size in the rabbit by activation of ATP-sensitive potassium channels. Br J Pharmacol (1996) 0.85
Expression, function, and regulation of E-type prostaglandin receptors (EP3) in the nonischemic and ischemic pig heart. Circ Res (1997) 0.84
Implication of protein kinase C-alpha, delta, and epsilon isoforms in ischemic preconditioning in perfused rat hearts. J Biochem (1997) 0.83
Influence of protein kinase C inhibitors on vasoconstrictor responses in the pulmonary vascular bed of cat and rat. Am J Physiol (1995) 0.82
Protection of the ischemic myocardium from reperfusion injury by prostaglandin E1 inhibition of ischemia-induced neutrophil activation. Naunyn Schmiedebergs Arch Pharmacol (1988) 0.82
Signal transduction in ischemic preconditioning. Z Kardiol (1995) 0.80
Attenuation of lipopolysaccharide fever in rats by protein kinase C inhibitors. Am J Physiol (1997) 0.80
Protection of the myocardium by ischaemic preconditioning: mechanisms and therapeutic implications. Pharmacol Ther (1996) 0.79
Eicosanoids and myocardial ischaemia. Basic Res Cardiol (1987) 0.79
Regulation of prostaglandin receptors in myocardial ischemia. Agents Actions Suppl (1995) 0.78
Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J Biol Chem (1999) 6.44
Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine. J Exp Med (2001) 5.06
Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci U S A (1993) 4.82
The skeletal muscle chloride channel in dominant and recessive human myotonia. Science (1992) 4.28
Impact of the agr quorum-sensing system on adherence to polystyrene in Staphylococcus aureus. J Infect Dis (2000) 4.19
Algorithm for neuropathic pain treatment: an evidence based proposal. Pain (2005) 3.92
The D-alanine residues of Staphylococcus aureus teichoic acids alter the susceptibility to vancomycin and the activity of autolytic enzymes. Antimicrob Agents Chemother (2000) 2.71
Circulating cell adhesion molecules and death in patients with coronary artery disease. Circulation (2001) 2.37
Retinal vascular occlusion and deficiencies in the protein C pathway. Am J Ophthalmol (1999) 2.37
The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure. Proc Natl Acad Sci U S A (1995) 2.36
Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol (1998) 2.35
Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock. Br J Pharmacol (1993) 2.32
Chitinase enzyme activity in CSF is a powerful biomarker of Alzheimer disease. Neurology (2012) 2.23
Membrane-permeable radical scavenger, tempol, reduces multiple organ injury in a rodent model of gram-positive shock. Crit Care Med (2000) 2.13
Mechanism of gram-positive shock: identification of peptidoglycan and lipoteichoic acid moieties essential in the induction of nitric oxide synthase, shock, and multiple organ failure. J Exp Med (1998) 2.08
Fatal late vitamin K-deficiency bleeding after oral vitamin K prophylaxis secondary to unrecognized bile duct paucity. J Pediatr Gastroenterol Nutr (1999) 1.98
Endothelial cells metabolize NG-monomethyl-L-arginine to L-citrulline and subsequently to L-arginine. Biochem Biophys Res Commun (1990) 1.94
Diagnosis of Creutzfeldt-Jakob disease by two-dimensional gel electrophoresis of cerebrospinal fluid. Lancet (1996) 1.91
Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase. Proc Natl Acad Sci U S A (1994) 1.83
Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options. Eur J Neurol (2009) 1.76
Proposal for a histopathological consensus classification of the periprosthetic interface membrane. J Clin Pathol (2006) 1.75
Definition and drivers of acute traumatic coagulopathy: clinical and experimental investigations. J Thromb Haemost (2010) 1.71
Isothioureas: potent inhibitors of nitric oxide synthases with variable isoform selectivity. Br J Pharmacol (1995) 1.67
Application of C1-esterase inhibitor during reperfusion of ischemic myocardium: dose-related beneficial versus detrimental effects. Circulation (2001) 1.64
Peptidoglycan and lipoteichoic acid from Staphylococcus aureus induce tumor necrosis factor alpha, interleukin 6 (IL-6), and IL-10 production in both T cells and monocytes in a human whole blood model. Infect Immun (2000) 1.58
Phospho-tau/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias. Mol Psychiatry (2003) 1.58
Beneficial effects of tempol, a membrane-permeable radical scavenger, on the multiple organ failure induced by zymosan in the rat. Crit Care Med (2001) 1.55
Value of CSF beta-amyloid1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment. Mol Psychiatry (2004) 1.53
Tempol, a membrane-permeable radical scavenger, reduces oxidant stress-mediated renal dysfunction and injury in the rat. Kidney Int (2000) 1.52
Mediation via different receptors of the vasoconstrictor effects of endothelins and sarafotoxins in the systemic circulation and renal vasculature of the anaesthetized rat. Br J Pharmacol (1993) 1.51
The selective guanylate cyclase inhibitor ODQ reduces multiple organ injury in rodent models of Gram-positive and Gram-negative shock. Crit Care Med (2001) 1.50
Effect of rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2 on bleomycin-induced lung injury. Eur Respir J (2005) 1.49
Cardiac troponins in serum in chronic renal failure. Clin Chem (1994) 1.49
Ictal scalp EEG in unilateral mesial temporal lobe epilepsy. Epilepsia (1998) 1.46
The functional organization of the interictal spike complex in benign rolandic epilepsy. Epilepsia (1996) 1.45
Impact of viral and bacterial infectious burden on long-term prognosis in patients with coronary artery disease. Circulation (2001) 1.44
Persistent strains of coagulase-negative staphylococci in a neonatal intensive care unit: virulence factors and invasiveness. Clin Microbiol Infect (2007) 1.43
Highly conserved and disease-specific patterns of carboxyterminally truncated Abeta peptides 1-37/38/39 in addition to 1-40/42 in Alzheimer's disease and in patients with chronic neuroinflammation. J Neurochem (2002) 1.40
Construction and characterization of an agr deletion mutant of Staphylococcus epidermidis. Infect Immun (2000) 1.39
1,161 patients with adrenal incidentalomas: indications for surgery. Langenbecks Arch Surg (2007) 1.34
Proximal myotonic myopathy: a new dominant disorder with myotonia, muscle weakness, and cataracts. Neurology (1994) 1.31
Platelet-activating factor contributes to the induction of nitric oxide synthase by bacterial lipopolysaccharide. Circ Res (1993) 1.29
Cytomegalovirus infection with interleukin-6 response predicts cardiac mortality in patients with coronary artery disease. Circulation (2001) 1.29
Structure-function relationships in the tryptophan-rich, antimicrobial peptide indolicidin. J Pept Sci (2001) 1.25
Lipocortin 1 mediates the inhibition by dexamethasone of the induction by endotoxin of nitric oxide synthase in the rat. Proc Natl Acad Sci U S A (1995) 1.24
Attenuation of the induction of nitric oxide synthase by endogenous glucocorticoids accounts for endotoxin tolerance in vivo. Proc Natl Acad Sci U S A (1994) 1.23
Intracoronary application of C1 esterase inhibitor improves cardiac function and reduces myocardial necrosis in an experimental model of ischemia and reperfusion. Circulation (1997) 1.23
Calpain inhibitor I reduces the activation of nuclear factor-kappaB and organ injury/dysfunction in hemorrhagic shock. FASEB J (2001) 1.23
Delayed circulatory failure due to the induction of nitric oxide synthase by lipoteichoic acid from Staphylococcus aureus in anaesthetized rats. Br J Pharmacol (1995) 1.22
Bacterial insertion sequence IS256 as a potential molecular marker to discriminate invasive strains from commensal strains of Staphylococcus epidermidis. J Hosp Infect (2005) 1.19
Staphylococcal alpha-phenol soluble modulins contribute to neutrophil lysis after phagocytosis. Cell Microbiol (2013) 1.19
Incomplete inhibition of the pressor effects of endothelin-1 and related peptides in the anaesthetized rat with BQ-123 provides evidence for more than one vasoconstrictor receptor. Br J Pharmacol (1993) 1.18
Association between P-selectin gene polymorphisms and soluble P-selectin levels and their relation to coronary artery disease. Arterioscler Thromb Vasc Biol (2001) 1.18
Large-scale, multicenter study of cerebrospinal fluid tau protein phosphorylated at serine 199 for the antemortem diagnosis of Alzheimer's disease. Ann Neurol (2001) 1.18
Invited opinion: role of nitric oxide in hemorrhagic, traumatic, and anaphylactic shock and thermal injury. Shock (1994) 1.18
Nucleotide sequence of one component of the banana bunchy top virus genome contains a putative replicase gene. J Gen Virol (1993) 1.17
Subcutaneous immunoglobulin in responders to intravenous therapy with chronic inflammatory demyelinating polyradiculoneuropathy. Eur J Neurol (2013) 1.17
Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock. Br J Pharmacol (1995) 1.16
Biomaterial-induced sarcoma: A novel model to study preneoplastic change. Am J Pathol (2000) 1.15
Nifedipine inhibits the induction of nitric oxide synthase by bacterial lipopolysaccharide. J Pharmacol Exp Ther (1993) 1.14
Detection of apoptosis in KG-1a leukemic cells treated with investigational drugs. Arzneimittelforschung (1996) 1.14
Relaxin activates the L-arginine-nitric oxide pathway in vascular smooth muscle cells in culture. Hypertension (1998) 1.13
Trauma alarmins as activators of damage-induced inflammation. Br J Surg (2012) 1.13
Incidentally discovered adrenal tumors: a lesson from observation of 1,444 patients. Horm Metab Res (2008) 1.10
Analysis of the signal transduction in the induction of nitric oxide synthase by lipoteichoic acid in macrophages. Br J Pharmacol (1996) 1.09
Purification of human natural killer cells using a clinical-scale immunomagnetic method. Cytotherapy (2003) 1.08
Tempol reduces infarct size in rodent models of regional myocardial ischemia and reperfusion. Free Radic Biol Med (1999) 1.07
Modification of energy metabolism and radiation response of a murine tumour by changes in nitric oxide availability. Biochem Biophys Res Commun (1993) 1.07
Novel method of biotyping Haemophilus influenzae that uses API 20e. J Clin Microbiol (1982) 1.06
Environmental aspects in pediatrics. New item in the European Journal of Pediatrics. Eur J Pediatr (1995) 1.06
Effect of calpain inhibitor I, an inhibitor of the proteolysis of I kappa B, on the circulatory failure and multiple organ dysfunction caused by endotoxin in the rat. Br J Pharmacol (1997) 1.06
Role of nitric oxide in the circulatory failure and organ injury in a rodent model of gram-positive shock. Br J Pharmacol (1996) 1.05
Calpain inhibitor I reduces the development of acute and chronic inflammation. Am J Pathol (2000) 1.05
Effects of tempol, a membrane-permeable radical scavenger, in a gerbil model of brain injury. Brain Res (2000) 1.05
Validation of amyloid-beta peptides in CSF diagnosis of neurodegenerative dementias. Mol Psychiatry (2007) 1.05
A recurrent 14 bp deletion in the CLCN1 gene associated with generalized myotonia (Becker). Hum Mol Genet (1994) 1.05
Endothelium-derived relaxing factor participates in the increased blood flow in response to pentagastrin in the rat stomach mucosa. Proc Biol Sci (1990) 1.04
Health-related quality of life (HRQOL), activity of daily living (ADL) and depressive mood disorder in temporal lobe epilepsy patients. Seizure (1999) 1.04
Interleukin-1 contributes to the induction of nitric oxide synthase by endotoxin in vivo. Eur J Pharmacol (1993) 1.04
Current trends in biocompatibility testing. Proc Inst Mech Eng H (1998) 1.03
Induction of NO synthesis by lipoteichoic acid from Staphylococcus aureus in J774 macrophages: involvement of a CD14-dependent pathway. Biochem Biophys Res Commun (1997) 1.03
The involvement of endothelium-derived relaxing factor in the regulation of renal cortical blood flow in the rat. Br J Pharmacol (1991) 1.02
Effect of interleukin-4 and interleukin-10 on leucocyte migration and nitric oxide production in the mouse. Br J Pharmacol (1995) 1.02
The hemodynamic effects of endothelin-1 in the pithed rat. J Cardiovasc Pharmacol (1989) 1.02
Effects of tyrphostins and genistein on the circulatory failure and organ dysfunction caused by endotoxin in the rat: a possible role for protein tyrosine kinase. Br J Pharmacol (1997) 1.02
Dihydropyridine antagonists and agonists of calcium channels inhibit the induction of nitric oxide synthase by endotoxin in cultured macrophages. Biochem Biophys Res Commun (1993) 1.01
Glibenclamide-induced inhibition of the expression of inducible nitric oxide synthase in cultured macrophages and in the anaesthetized rat. Br J Pharmacol (1995) 1.01
Induction of hypoxia in experimental murine tumors by the nitric oxide synthase inhibitor, NG-nitro-L-arginine. Cancer Res (1994) 1.01
A large-scale method for the selective depletion of alphabeta T lymphocytes from PBSC for allogeneic transplantation. Cytotherapy (2007) 1.01
Early age-related cognitive impairment in mice lacking cannabinoid CB1 receptors. Proc Natl Acad Sci U S A (2005) 0.99
Calpain inhibitor I reduces colon injury caused by dinitrobenzene sulphonic acid in the rat. Gut (2001) 0.99
Sirolimus interferes with the innate response to bacterial products in human whole blood by attenuation of IL-10 production. Scand J Immunol (2001) 0.98
Peptidoglycan primes for LPS-induced release of proinflammatory cytokines in whole human blood. Shock (2001) 0.98
Lipoteichoic acid induces delayed protection in the rat heart: A comparison with endotoxin. Arterioscler Thromb Vasc Biol (2000) 0.98